Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06810375 · ClinicalTrials.gov registry record · Phase 3
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
A Phase 3 study of Lung Cancers, sponsored by George Washington University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06810375 is a Phase 3 study of Lung Cancers that is actively recruiting participants, run by George Washington University. The registered enrollment target is 120 participants, below the 158-participant average among 5 other Lung Cancers trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06810375, a Phase 3 study of Lung Cancers, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Conditions Studied
Interventions
- DRUG Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
- DRUG Intercostal nerve block
Study Locations (1)
District of Columbia
- The George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2029-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06810375
The ClinicalTrials.gov registry entry for NCT06810375 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 158-participant average among 5 other Lung Cancers trials with a reported enrollment target (24% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancers appearing as the primary indexed condition, and to 2 interventions - of which Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) is the first listed.
NCT06810375 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06810375 about?
NCT06810375 is a clinical study titled "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery". This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
What is the current status of trial NCT06810375?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2025-03-01. Estimated completion is 2029-02-28.
What conditions does trial NCT06810375 study?
This clinical trial studies the following conditions: Lung Cancers.
What interventions are being tested in trial NCT06810375?
The interventions under investigation include: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) (DRUG), Intercostal nerve block (DRUG).
Who is sponsoring clinical trial NCT06810375?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06810375 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rapid Autopsy and Procurement of Cancer Tissue
RECRUITING
-
Bright Light Therapy on Sleep Health in Lung Cancer Patients
RECRUITING · NA
-
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RECRUITING · Phase 1
-
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.